Discontinuation report LEVITRA
| Report ID | 121585 |
| Drug Identification Number | 02250462 |
| Brand name | LEVITRA |
| Common or Proper name | Vardenafil |
| Company Name | BAYER INC |
| Market Status | CANCELLED POST MARKET |
| Active Ingredient(s) | VARDENAFIL |
| Strength(s) | 5MG |
| Dosage form(s) | TABLET |
| Route of administration | ORAL ORAL |
| Packaging size | 4's |
| ATC code | G04BE |
| ATC description | OTHER UROLOGICALS, INCL ANTISPASMODICS |
| Reason for discontinuation | Business reasons |
| Anticipated discontinuation date | 2020-09-30 |
| Actual discontinuation date | 2020-11-16 |
| Remaining supply date | 2019-11-30 |
| Discontinuation status | Discontinued |
| Discontinuation decision reversal | No |
| Information on remaining supply | |
| Company comments | |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 2920 MATHESON BLVD EAST MISSISSAUGA, ONTARIO CANADA L4W 5R6 |
| Company contact information | 1-800-265-7382 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v4 | 2020-11-20 | French | Compare |
| v3 | 2020-11-20 | English | Compare |
| v2 | 2020-07-31 | French | Compare |
| v1 | 2020-07-31 | English | Compare |
Showing 1 to 4 of 4